December 8, 2025Blood

More than IL-2: Optimizing feeder-free NK cell function through cytokine synergy

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observation reveals enhanced antitumor activity in NK cell therapies for chronic myeloid leukemia, suggesting promising clinical applications.

Antitumor activity peaked significantly with IL-2 and IL-15 combinations, outperforming traditional cytokine protocols.
NK cells showed improved cytotoxic activity against chronic myeloid leukemia cell line K562 in cytokine-rich environments.
Assessment using flow cytometry confirmed increased degranulation and activation in optimized NK cell cultures.
These findings highlight potential for more effective, clinical-scale NK cell therapies using novel cytokine combinations.

Warmuzová et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 8, 2025Blood

View Full Paper

Ask AI

Bookmark

Authors

Observation reveals enhanced antitumor activity in NK cell therapies for chronic myeloid leukemia, suggesting promising clinical applications.

Antitumor activity peaked significantly with IL-2 and IL-15 combinations, outperforming traditional cytokine protocols.
NK cells showed improved cytotoxic activity against chronic myeloid leukemia cell line K562 in cytokine-rich environments.
Assessment using flow cytometry confirmed increased degranulation and activation in optimized NK cell cultures.
These findings highlight potential for more effective, clinical-scale NK cell therapies using novel cytokine combinations.

Warmuzová et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark